A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen.

about

The effect of CYP2D6 *10 polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis.Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients.

P2860

Q45987663-F941909C-0CA9-43C8-8CED-A1DEF222A2B9 Q47099651-07182849-2E5B-4E7B-8793-F6A0E2826F7E

P2860

A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen.

Item

http://www.wikidata.org/entity/Q40639052

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

A pooled analysis of CYP2D6 ge ...... trials of low-dose tamoxifen.

@en

type

Item

label

A pooled analysis of CYP2D6 ge ...... trials of low-dose tamoxifen.

@en

prefLabel

A pooled analysis of CYP2D6 ge ...... trials of low-dose tamoxifen.

@en

P1476

A pooled analysis of CYP2D6 ge ...... trials of low-dose tamoxifen.

@en

P2093

Andrea DeCensi

http://www.w3.org/2001/XMLSchema#string

Bernardo Bonanni

http://www.w3.org/2001/XMLSchema#string

Davide Serrano

http://www.w3.org/2001/XMLSchema#string

Ernst Lien

http://www.w3.org/2001/XMLSchema#string

Gunnar Mellgren

http://www.w3.org/2001/XMLSchema#string

Jennifer Gjerde

http://www.w3.org/2001/XMLSchema#string

Monia Lattanzi

http://www.w3.org/2001/XMLSchema#string

Valentina Aristarco

http://www.w3.org/2001/XMLSchema#string

P2860

Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.

Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.

A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer

PharmGKB summary: tamoxifen pathway, pharmacokinetics

Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review.

Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomes.

Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen

Association between genetic polymorphisms of CYP2D6 and outcomes in breast cancer patients with tamoxifen treatment

P2888

s10549-016-3932-7

P304

97-108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-016-3932-7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

159

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1017106100

http://www.w3.org/2001/XMLSchema#string

P698

27484880

http://www.w3.org/2001/XMLSchema#string

A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen.

about

P2860

P2860

A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698